ArticleBMC cancer2013

CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy.

Khalilullah Mia-Jan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.